EP Patent

EP0908181B1 — Remedy for rosacea

Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2009-01-14 · 17y expired

What this patent protects

A remedy for rosacea being efficacious even against intractable rosacea which cannot be completely cured by using remedies comprising antibiotics such as minocycline and having a low toxicity, little side effects and a long-lasting drug effect. The remedy for rosacea contains as …

USPTO Abstract

A remedy for rosacea being efficacious even against intractable rosacea which cannot be completely cured by using remedies comprising antibiotics such as minocycline and having a low toxicity, little side effects and a long-lasting drug effect. The remedy for rosacea contains as the active ingredient at least one compound selected from the group consisting of benzo-heterocyclic derivatives represented by general formula (1) and salts thereof, wherein R represents lower alkyl; and X represents halogeno.

Drugs covered by this patent

Patent Metadata

Patent number
EP0908181B1
Jurisdiction
EP
Classification
Expires
2009-01-14
Drug substance claim
No
Drug product claim
No
Assignee
Otsuka Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.